Epigenetics Core
表观遗传学核心
基本信息
- 批准号:10380647
- 负责人:
- 金额:$ 26.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAcetylationAcuteAddressAffectAlcohol consumptionAlcohol withdrawal syndromeAlcoholsAmygdaloid structureAntibodiesAutopsyBioinformaticsBiological AssayBrainBrain regionCatalytic DomainChIP-seqChimeric ProteinsChromatinChronicComplementConsultConsultationsDNA MethylationDataData SetDeacetylationDevelopmentDietEP300 geneEpigenetic ProcessEthanolFemaleFunctional disorderFundingGenderGene ExpressionGene Expression RegulationGenerationsGenesGenomeGenomicsGlucocorticoid ReceptorGoalsGuidelinesHippocampus (Brain)Histone AcetylationHistonesHumanHuman ResourcesIndividualLinkLiquid substanceLocationMeasuresMediatingMessenger RNAMethylationNR3C1 geneNew South WalesPathway AnalysisPhenotypePlayPrefrontal CortexProteinsProtocols documentationQuality ControlQuantitative Reverse Transcriptase PCRRNARattusRegulator GenesRegulatory ElementResearchResearch PersonnelResearch Project GrantsResourcesRodentRoleSelf AdministrationSiteTechnologyTestingTissuesTrainingTransferaseTransposaseUnited States National Institutes of HealthUniversitiesVentral Tegmental AreaWithdrawalalcohol exposurealcohol researchalcohol use disorderbasebead chipbioinformatics pipelinechromatin remodelingcohortdemethylationdisorder controldrinking behaviorgene networkgenome-widegenome-wide analysisgenomic locushistone methylationhistone modificationhuman subjectin vivoinnovationinsightlarge datasetsmRNA Expressionmalemultiple datasetsnovelp300/CBP-Associated Factorpre-clinicalproblem drinkerpromoterresponsetissue resourcetooltranscription factortranscriptome sequencing
项目摘要
Project Summary
The goal of the Epigenetics Core is to provide a robust common platform for the identification and analysis of
genes affected by withdrawal from chronic ethanol exposure in the brain. During the current funding period, the
Epigenetics Core identified gene networks both induced and repressed by alcohol exposure or withdrawal in the
amygdala, hippocampus, ventral tegmental area and limbic cortex and specific target genes that showed
changes in RNA levels, as well as, in H3K9/14ac levels were functionally validated.
In the current submission, the proposed Aims will allow preclinical CARE Research Projects (Projects 1-3)
to obtain novel information regarding genome-wide changes in chromatin accessibility (ATAC-seq) and histone
methylation (H3K27me3 ChIP-seq). These findings will be integrated with data obtained during the current
funding period (RNA-seq and H3K9/14ac ChIP-seq). We will also perform ATAC-seq and RNA-seq in the
prefrontal cortex (PFC) of the alcohol use disorder (AUD)/control cohort obtained from the New South Wales
Tissue Resource Center (Project 4). In addition, we will investigate the across genome levels of 5-
hydroxymethylcytosine (5hmC) in the same tissue using Illumina’s EPIC Methylation Array. Results from these
studies will reveal brain region-selective changes in genes that are likely to contribute to alcohol use disorders.
The above studies constitute Aim 1 of the Core. Aim 2 proposes bioinformatics pipelines for the analyses of the
genome-wide datasets and the 5hmC array and integrating the large datasets for both preclinical and post-
mortem studies. The integration of datasets from multiple non-biased approaches is innovative and will provide
context for interpreting changes in the gene regulatory landscape in response to withdrawal from alcohol. In Aim
3, we propose to employ a novel dCas9:P300 acetyl transferase fusion protein to alter acetylation levels at
specific genomic loci. This will allow us to activate expression of key genes in specific brain regions by altering
acetylation selectively at their corresponding promoters. Similarly, we will use a dCas9:Tet1 fusion protein to
alter 5mC and 5hmC levels at glucocorticoid receptor (Nr3c1) to modulate mRNA expression.
The Epigenetics Core is using state-of-the-art technology to obtain genome-wide information to provide
additional resources for each CARE component to address their specific hypotheses. The Core will perform
quality control measures at many of the key steps of the protocols described above. In addition, key findings in
the genome-wide measures will be validated by Core personnel in consult with Project leaders. The Epigenetics
Core is an important platform, not only for individual CARE Projects, but also for University-wide NIH-funded
epigenetics investigators.
项目摘要
表观遗传学核心的目标是提供一个强大的通用平台,用于识别和分析
大脑中受慢性乙醇暴露影响的基因。在本资助期内,
表观遗传学核心鉴定了在成年人中由酒精暴露或戒断诱导和抑制的基因网络。
杏仁核,海马,腹侧被盖区和边缘皮层和特定的靶基因,
RNA水平以及H3 K9/14 ac水平的变化在功能上得到验证。
在当前提交文件中,拟定的目标将允许临床前CARE研究项目(项目1-3)
为了获得关于染色质可及性(ATAC-seq)和组蛋白的全基因组变化的新信息,
甲基化(H3 K27 me 3 ChIP-seq)。这些调查结果将与本报告期间获得的数据相结合。
(RNA-seq和H3K9/14ac ChIP-seq)。我们还将在实验室中进行ATAC-seq和RNA-seq。
来自新南威尔士州的酒精使用障碍(AUD)/对照队列的前额叶皮层(PFC)
组织资源中心(项目4)。此外,我们还将研究5-
使用Illumina的EPIC甲基化阵列在相同组织中检测羟甲基胞嘧啶(5 hmC)。从这些
研究将揭示可能导致酒精使用障碍的基因的大脑区域选择性变化。
上述研究构成了《核心》的目标1。目标2提出了生物信息学管道,用于分析
全基因组数据集和5 hmC阵列,并整合临床前和临床后的大型数据集,
尸检从多个无偏见的方法的数据集的整合是创新的,将提供
背景下解释的变化,基因调控景观,以响应从酒精戒断。在Aim中
3,我们提出采用新的dCas 9:P300乙酰转移酶融合蛋白来改变乙酰化水平,
特定的基因位点这将使我们能够通过改变大脑中特定区域的关键基因来激活它们的表达。
在其相应的启动子处选择性地乙酰化。类似地,我们将使用dCas 9:Tet 1融合蛋白来
改变糖皮质激素受体(Nr 3c 1)的5 mC和5 hmC水平以调节mRNA表达。
表观遗传学核心正在使用最先进的技术来获得全基因组信息,
为每个援外社组成部分提供额外资源,以解决其具体假设。核心将执行
在上述方案的许多关键步骤中进行质量控制措施。此外,
全基因组测量将由核心人员与项目负责人协商后进行验证。表观遗传学
核心是一个重要的平台,不仅对个人的关怀项目,而且对大学范围内的NIH资助
表观遗传学研究者
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS R GRAYSON其他文献
DENNIS R GRAYSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS R GRAYSON', 18)}}的其他基金
REGULATION OF GABA-A RECEPTOR SUBUNIT EXPRESSION
GABA-A 受体亚基表达的调控
- 批准号:
2268490 - 财政年份:1993
- 资助金额:
$ 26.71万 - 项目类别:
REGULATION OF GABA-A RECEPTOR SUBUNIT EXPRESSION
GABA-A 受体亚基表达的调控
- 批准号:
2259658 - 财政年份:1993
- 资助金额:
$ 26.71万 - 项目类别:
REGULATION OF GABA-A RECEPTOR SUBUNIT EXPRESSION
GABA-A 受体亚基表达的调控
- 批准号:
2268489 - 财政年份:1993
- 资助金额:
$ 26.71万 - 项目类别:
相似海外基金
Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
- 批准号:
EP/Y000331/1 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别:
Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
- 批准号:
10677295 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
- 批准号:
10635599 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
- 批准号:
10752320 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
- 批准号:
478927 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别:
Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
- 批准号:
10855703 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
- 批准号:
10654210 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
- 批准号:
10667952 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
- 批准号:
10726986 - 财政年份:2023
- 资助金额:
$ 26.71万 - 项目类别: